QA: Neurotrope Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513856_2018_Neurotrope_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001513856, Neurotrope Inc

  xvar xval
0 AssetsCurrent 16,423,587
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 20,655
3 remainder_Assets 0
4 LiabilitiesCurrent 1,558,283
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,083,149
9 ResearchAndDevelopmentExpense 4,488,717
10 remainder_Expenses 3,002,571
11 remainder_Revenues 0
12 remainder_NetIncome 243,182
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 16,444,242
1 Liabilities 1,558,283
2 Expenses 13,574,437
3 Revenues 0
4 StockholdersEquity 14,885,959
5 NetIncome -13,331,255
6 ComprehensiveNetIncome -13,331,255
7 BaseVar 15,910,072
8 EconomicCapitalRatiobeforeLimitedLiability 2.12
9 EconomicCapitalRatio 3.11

Edgar->Model Mapping

Feature Distribution

Change over Time